These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 11957423
21. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? Danne T, Kordonouri O. J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665 [Abstract] [Full Text] [Related]
22. Antihypertensive agents for prevention of diabetic nephropathy. Dressler RL. Am Fam Physician; 2006 Jul 01; 74(1):77-9. PubMed ID: 16848380 [No Abstract] [Full Text] [Related]
23. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A, Bashir K, Anwar E. Nepal Med Coll J; 2007 Jun 01; 9(2):79-83. PubMed ID: 17899953 [Abstract] [Full Text] [Related]
24. Clinical practice. Nephropathy in patients with type 2 diabetes. Remuzzi G, Schieppati A, Ruggenenti P. N Engl J Med; 2002 Apr 11; 346(15):1145-51. PubMed ID: 11948275 [No Abstract] [Full Text] [Related]
28. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S, ONTARGET and TRANSCEND Investigators. Arch Intern Med; 2011 Jan 24; 171(2):142-50. PubMed ID: 21263104 [Abstract] [Full Text] [Related]
29. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria. Lovell HG. Cochrane Database Syst Rev; 2001 Jan 24; (1):CD002183. PubMed ID: 11279757 [Abstract] [Full Text] [Related]
31. Best practice for hypertensive patients with kidney disease. de Zeeuw D. Hosp Med; 2003 Feb 24; 64(2):96-100. PubMed ID: 12619337 [Abstract] [Full Text] [Related]
32. Should all diabetic patients take ACE inhibitors, even those without proteinuria? Hoogwerf BJ. Cleve Clin J Med; 1999 Apr 24; 66(4):208-9. PubMed ID: 10199056 [No Abstract] [Full Text] [Related]
33. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?]. Os I, Stenehjem A, Høieggen A, Draganov B, Jenssen T, Holdaas H. Tidsskr Nor Laegeforen; 2002 Apr 10; 122(9):918-20. PubMed ID: 12082835 [Abstract] [Full Text] [Related]
34. Reducing renal disease in diabetes. Mason P, Gerntholtz T. Practitioner; 2001 Jun 10; 245(1623):557-61. PubMed ID: 11436266 [No Abstract] [Full Text] [Related]
35. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. Donnelly R, Yeung JM, Manning G. J Hypertens Suppl; 2003 Mar 10; 21(1):S7-12. PubMed ID: 12769161 [Abstract] [Full Text] [Related]
36. Clinical inquiries. Does screening for microalbuminuria in diabetes prevent complications? Hale WA, Nashelsky J, Wilson SA. J Fam Pract; 2003 Mar 10; 52(3):229-31. PubMed ID: 12620179 [No Abstract] [Full Text] [Related]
38. [Ambitious American guidelines for control of risk factors in diabetes. Was the aim put too high?]. Nilsson P, Attvall S, Weiss L. Lakartidningen; 2003 Jan 09; 100(1-2):26-30. PubMed ID: 12572133 [No Abstract] [Full Text] [Related]
39. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria. Lovell HG. Cochrane Database Syst Rev; 2000 Jan 09; (2):CD002183. PubMed ID: 10796871 [Abstract] [Full Text] [Related]
40. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. Agha A, Amer W, Anwar E, Bashir K. Saudi J Kidney Dis Transpl; 2009 May 09; 20(3):429-35. PubMed ID: 19414946 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]